TP53 and melanoma: SPARC has also been shown to have proliferative, as well as anti-apoptotic effects; depletion of SPARC by siRNA technology has been demonstrated to cause cell cycle arrest by activation of p53 and the p21Cip1/Waf1 pathway in melanoma cells [35].